Larvol Delta - Aulos-Bioscience-Advances-AU007-to-Phase-2-Portion-of-Phase-12-Study-Evaluating-Computationally-Designed-IL2-Antibody-for-Treatment-of-Solid-Tumors

AU-007 - Aulos Biosci

https://www.businesswire.com/news/home/20231218885955/en/Aulos-Bioscience-Advances-AU-007-to-Phase-2-Portion-of-Phase-12-Study-Evaluating-Computationally-Designed-IL-2-Antibody-for-Treatment-of-Solid-Tumors

Dec 18, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next